ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC By Ogkologos - April 16, 2015 467 0 Facebook Twitter Google+ Pinterest WhatsApp Final results from the IGNITE study Source RELATED ARTICLESMORE FROM AUTHOR No OS Improvement with CDK4/6 Inhibitors Used in First- Compared with Second-Line Treatment in Patients with HR-positive, HER2-negative ABC Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe MOST POPULAR Avapritinib Approved to Treat GIST with a Rare Gene Alteration February 6, 2020 Fewer Women with Ovarian, Breast Cancer Undergo Genetic Testing than Expected April 9, 2019 “No Person With Cancer or Survivor Should Ever Feel Alone”: A... June 2, 2021 TG4001 Therapeutic Vaccination Plus Avelumab-Mediated PD-L1 Blockade Improves Tumour Microenvironment in... December 12, 2020 Load more HOT NEWS First Study to Demonstrate that PD1 Immune Checkpoint Blockade May Yield... Breaking News: Medical Debt and Your Credit Report New treatment for Waldenstrom’s macroglobulinaemia in England ΚΑΡΚΙΝΟΣ ΘΥΡΕΟΕΙΔΟΥΣ
